Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004076 | Panoply™ Human DCD Knockdown Stable Cell Line | Inquiry |
| CSC-SC004076 | Panoply™ Human DCD Over-expressing Stable Cell Line | Inquiry |
| CLOE-0180 | Human DCD HEK293 Cell Lysate | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| LV10377L | human DCD (NM_053283) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH275073 | shRNA set against Human DCD (NM_053283.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCB158265 | Human DCD ORF clone (BC062682) | Inquiry |
| MiUTR1H-02685 | DCD miRNA 3'UTR clone | Inquiry |
| CDCS416606 | Human DCD ORF Clone (BC062682) | Inquiry |
The Dermcidin (DCD) gene, located on chromosome 8, is a highly conserved gene that plays a significant role in the regulation of various physiological processes, including cell differentiation, development, and stress responses. The gene encodes a protein called Dermcidin (DCD), which is a member of the small heat shock protein (sHSP) family. DCD is known to be involved in protecting cells from various environmental stresses such as heat, cold, and oxidative stress.
The DCD gene is composed of 12 exons and the length of the encoded protein is 131 amino acids. The protein is characterized by a highly conserved N-terminal domain, a central alpha-Helical structural domains and a C-terminal domain. The N-terminal domain is responsible for the chaperone activity of DCD, which helps to protect cells from oxidative stress and other environmental stresses. These central alpha-Helical structural domains are involved in the dimerization of DCD, which is necessary for its chaperone activity. The C-terminal domain is responsible for the interaction of DCD with other cellular components and plays a role in the localization of the protein within the cell.
The DCD gene is regulated by various transcription factors and signaling pathways. One of the key regulators of DCD expression is the heat shock factor (HSF) protein. HSF binds to the heat shock element (HSE) present in the promoter region of the DCD gene and activates its transcription. Otherwise, DCD expression can also be regulated by other transcription factors such as basic leucine zipper (bZIP) proteins, nuclear factor-κB (NF-κB), and activating transcription factor 2 (ATF2).
DCD gene plays a crucial role in the process of cancerogenesis. DCD is a natural antimicrobial peptide encoded by the DCD gene, which is expressed in various tissues, including skin, lung, and prostate. Increasing evidence suggests that DCD expression is dysregulated in many types of cancers, contributing to the development and progression of the disease. In cancer cells, the DCD gene undergoes mutations and abnormal expressions, leading to its functional impairment. These mutations can cause the cells to lose normal growth control, enabling them to divide uncontrollably and form tumors. Moreover, DCD's antimicrobial function is also disrupted in cancer cells, leading to increased susceptibility to infections, which is common in cancer patients. The role of DCD in cancer progression is multifaceted. It has been implicated in promoting angiogenesis, the formation of new blood vessels that supply nutrients and oxygen to tumors. Additionally, DCD can modulate immune cell function, influencing the immune response against cancer cells. Furthermore, it interacts with various signaling pathways, such as the MAPK and PI3K/Akt pathways, which are critical for cancer cell survival and proliferation.
Figure 1. DCD may be involved in a few processes of many types of cancer cells.
References: